Tailoring the Hydroxyl Radical Footprinting Approach to Provide a Solution for the Higher Order Structural Analytical Needs of the Biopharmaceutical Industry
定制羟基自由基足迹方法,为生物制药行业的高阶结构分析需求提供解决方案
基本信息
- 批准号:9408491
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdenineAdoptionAdverse Drug Experience ReportAppearanceBiological ProductsBiological Response Modifier TherapyCessation of lifeChemicalsComparative StudyComplexCustomDevelopmentDevicesDimensionsEnvironmentFASTK GeneFeedbackGeneric DrugsGoalsGovernmentGuidelinesHealth Care CostsHealthcare SystemsHigher Order Chromatin StructureHydroxyl RadicalImmune responseIndustryLabelLaboratoriesLasersLegal patentLettersLinkMeasurementMethodsMorbidity - disease rateNaturePatientsPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePhysiologic pulsePlayPreparationProcessProductionProtein AnalysisProteinsReactionReproducibilityResearchRoleSafetySalesSamplingSmall Business Innovation Research GrantStressStructureSystemTechniquesTechnologyTestingTimeUltraviolet Raysanalytical toolcombatcost effectiveexperimental studyexpirationimprovedinfliximabinnovationinstrumentirritationnew technologynoveloxidationprogramsprotein profilingprotein structureresearch and developmenttool
项目摘要
The GenNext submssion entitled “Tailoring the Hydroxy Radical Foot-Printing
Approach to Provide a Solution for the Higher Order Structural Analysis Needs of the
Biopharmaceutical Industry” is responsive to the ackowledged need for new and
improved tools for higher order structural analysis (HOS) of biopharmaceuticals. Unlike
conventional drugs, biopharmaceuticals are complex, heterogeneous mixtures of 3-
dimensional biomolecules, whose safety and efficacy is reliant upon proper HOS. The
presence of proteins with improper higher order structure (HOS) has been linked to
severe adverse drug reactions (ADR), alerting the biopharmaceutical industry to the
critical role of HOS, while establishing the need for new and improved HOS analytics.
An emerging HOS analysis technique is hydroxyl radical foot-printing (HRPF).
HRPF involves the irreversible labeling of a protein's exterior by reaction with hydroxyl
radicals with subsequent MS analysis to identify the outer portions of the protein. The
most widely used method for generating OH radicals employs a quick burst of UV light,
and is appropriately called fast photochemical oxidation of proteins (FPOP). Typically, a
powerful and expensive UV laser is used. Academic laboratories have demonstrated the
utility of FPOP for HOS analysis; however adoption in pharma has been minuscule at
best. We have identified barriers that have limited the adoption of the HRPF approach in
the biopharmaceutical industry. These impediments include: 1) The use of expensive
lasers that demand substantial safety precautions; and 2) the irreproducibility of FPOP
caused by background scavenging of OH radicals that complicate and limit comparative
studies. As such, there are no commercial sample preparation devices for FPOP
analysis, despite the demonstrated need for the HOS analytical power.
The GenNext proposal creates an improved means of performing HRPF analysis
by replacing expensive, hazardous lasers with a flash oxidation system. Moreover, a
custom internal standard (actinometry) system will be included to facilitate ease of use
and improve reproducibility. These innovative advancements will decrease the barrier to
adoption of HRPF for HOS analysis and will result in accelerated adoption with
concomitant impact on biopharmaceutical research and development.
GenNext提交的题为"定制羟基自由基足迹
一种解决高层建筑结构分析需要的方法
生物制药业"是响应知识的需要,新的和
用于生物制药的高阶结构分析(HOS)的改进工具。不像
传统药物,生物药物是复杂的,3-
三维生物分子,其安全性和有效性依赖于适当的HOS。的
具有不适当的高级结构(HOS)的蛋白质的存在与以下因素有关:
严重药物不良反应(ADR),提醒生物制药行业注意
HOS的关键作用,同时建立新的和改进的HOS分析的需要。
一种新兴的HOS分析技术是羟基自由基足迹法(HRPF)。
HRPF涉及通过与羟基反应对蛋白质的外部进行不可逆标记
随后进行MS分析以鉴定蛋白质的外部部分。的
最广泛使用的产生OH自由基的方法采用紫外光的快速爆发,
并被适当地称为蛋白质的快速光化学氧化(FPOP)。通常
使用强大而昂贵的UV激光器。学术实验室已经证明,
FPOP用于HOS分析的实用性;然而,在制药行业的采用率微乎其微,
最好我们已经查明了限制采用HRPF方法的障碍,
生物制药行业。这些障碍包括:1)使用昂贵的
需要大量安全预防措施的激光; 2)FPOP的不可再现性
这是由于OH自由基的背景清除造成的,
问题研究因此,没有用于FPOP的商业样品制备装置
分析,尽管证明需要HOS分析能力。
GenNext提案创建了执行HRPF分析的改进方法
用闪光氧化系统代替昂贵的危险激光器。而且
将包括定制的内标(光化测定)系统,以便于使用
并提高再现性。这些创新性的进步将减少
采用HRPF进行居屋计划分析,并会加快采用,
对生物制药研究和开发的共同影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scot Randy Weinberger其他文献
Scot Randy Weinberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scot Randy Weinberger', 18)}}的其他基金
Liquid Chromatography Flash Oxidation (LC-Fox™) Protein Footprinting System
液相色谱闪蒸氧化 (LC-Fox™) 蛋白质足迹系统
- 批准号:
10698726 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Multi-Wavelength Fluorescence Radical Dosimetry for Real-Time Assessment of Protein Footprinting Radical Yield
用于实时评估蛋白质足迹自由基产量的多波长荧光自由基剂量测定
- 批准号:
10250755 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System
细胞内自动闪式氧化 (IC-AutoFox™) 蛋白质足迹系统
- 批准号:
10589128 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System
细胞内自动闪式氧化 (IC-AutoFox™) 蛋白质足迹系统
- 批准号:
10478371 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
In-Cell Radical Dosimetry (ICRD) for improved in vivo Fast Photo-oxidation of Proteins Hydroxyl Radical Protein Footprinting
细胞内自由基剂量测定 (ICRD),用于改善蛋白质体内快速光氧化羟基自由基蛋白质足迹
- 批准号:
10009765 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10379422 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10257385 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity
用于确定蛋白质异质性和蛋白质表达保真度的软件
- 批准号:
10582584 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis
FoxWare™,一种用于羟基自由基足迹高阶结构分析的高级数据分析包
- 批准号:
10092185 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis
FoxWare™,一种用于羟基自由基足迹高阶结构分析的高级数据分析包
- 批准号:
10334462 - 财政年份:2018
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10534031 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Pathways of Succinate Accumulation and Adenine Nucleotide Depletion in Cardiac Ischemia
心脏缺血中琥珀酸积累和腺嘌呤核苷酸消耗的途径
- 批准号:
10794933 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Development of nobel assay methods for miRNA and adenine methyltransferase using FRET
使用 FRET 开发 miRNA 和腺嘌呤甲基转移酶的诺贝尔检测方法
- 批准号:
21K05120 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Critical assessment of DNA adenine methylation in brain cells from healthy aging and Alzheimer's disease
健康老龄化和阿尔茨海默病脑细胞 DNA 腺嘌呤甲基化的批判性评估
- 批准号:
10365337 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10033546 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10613902 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10226235 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10396102 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别:
DNA Methylation at N6-Adenine in Placental Trophoblast Development
胎盘滋养层发育中 N6-腺嘌呤 DNA 甲基化
- 批准号:
10705982 - 财政年份:2020
- 资助金额:
$ 22.5万 - 项目类别: